Overview

For most of the history of biological hair restoration, the clinical goal has been the same: deliver growth factors to the follicle and allow the follicular cells to respond. PRP does this. GFC does it more potently. Both work through growth factor-receptor binding — the growth factor reaching the cell surface, binding to a specific receptor, and initiating a signalling cascade that instructs the cell to proliferate, extend its growth phase, produce more growth factors of its own. The cell receives a message from outside. It responds.

Exosome therapy changes the question. Rather than delivering messages to the surface of the cell, exosomes are taken up into the cell itself — through endocytosis, in which the cell membrane engulfs the vesicle and internalises its contents. What those contents include, in the case of mesenchymal stem cell-derived exosomes, is not only growth factors — it is also microRNA, the short non-coding RNA sequences that function as genetic regulators, binding to messenger RNA within the cell and modulating which proteins are translated from it. MicroRNA can influence gene expression — shifting the biological behaviour of the cell not by instructing it from outside, but by changing what the cell itself produces and how it behaves.

Dutexome is the exosome preparation used at Ministry of Skin — manufactured from rigorously screened mesenchymal stem cell cultures under pharmaceutical-grade controlled conditions, standardised to a consistent potency and molecular profile in every vial. Where PRP and GFC vary in potency with the individual patient's platelet biology, Dutexome delivers the same biological payload — the same precise concentration of growth factors, proteins, lipids, and microRNA — regardless of individual variation.

What Dutexome Actually Does in the Follicle

When Dutexome exosomes reach the scalp tissue following injection, they are taken up by follicular cells — dermal papilla cells, follicular stem cells, outer root sheath keratinocytes — through endocytosis. Once inside, the exosomes release their cargo: growth factors that amplify the follicular growth signal from within the cell, proteins that support cellular survival, and the microRNA sequences that regulate the expression of genes involved in follicular stem cell activation, dermal papilla cell survival, angiogenesis in the perifollicular environment, and the duration of the anagen growth phase.

The clinical consequence is a follicular reprogramming — a sustained shift in the biological behaviour of the treated follicle toward a more regenerative state that persists for weeks and months after the exosomes themselves have been metabolised. The follicle is not simply stimulated by an external signal that fades when the signal is removed. It has been changed, at the molecular level, in a way that continues to express itself in the hair it produces. This is the distinction that makes Dutexome Exosome therapy genuinely different from the biological treatments that preceded it.